AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Find out where to locate credit cards that offer cash back bonuses. Discover deals that can enhance your overall spending power.
22,627 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
GPIQ has drawn billions with a near-10% yield by selling call options on mega-cap tech. The strategy injects income b...
A couple can retire at 65 in Colorado's Rockies on a $1.2 million nest egg by selecting affordable mountain towns and...
Two logistics giants, UPS and FedEx, are navigating a shifting world of e commerce, global trade, and pricing pressur...
Strategy increases its USD cash pile by $450 million via a stock offering, bringing total USD reserves to $3 billion ...
As UCB prepares to reveal Q2 results, investors should focus on revenue mix, pipeline progress, and margin resilience...
DHT Holdings has benefited from surging tanker rates and a policy of distributing all ordinary net income as dividend...
DigitalOcean beats Q4 2025 expectations as AI-driven ARR surges to $120 million, lifting revenue to $242 million and ...
Insider moves during earnings season can spark questions about a company’s future. This article dives into what it me...
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...
Midwest apartment markets are turning brighter as rents rise and debt costs ease. BAM Capital now offers accredited i...
AppLovin exposes investors to a volatile mix of ad spend cycles and AI disruption fears. This guide breaks down the d...